AIM ImmunoTech, Inc. (AIM)

1.18 -0.16 (-11.94%) USD  |  NYAM  |  Jan 20, 16:00
1.20 +0.02 (+1.69%) After-Hours: 20:00
More

AIM ImmunoTech Other Long Term Assets (Quarterly)

Other Long Term Assets (Quarterly) Chart

View Other Long Term Assets (Quarterly) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Long Term Assets (Quarterly) Range, Past 5 Years

View Other Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Long Term Assets (Quarterly) Benchmarks

View Other Long Term Assets (Quarterly) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. --
Electromed, Inc. --
Armata Pharmaceuticals, Inc. Upgrade